Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parentheticals)

v3.23.1
Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Jan. 31, 2023
Jan. 31, 2022
Accounts receivable, reserves $ 221 $ 125
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 375,000,000 375,000,000
Common stock, shares issued (in shares) 163,655,881 133,258,027
Common Stock, Shares, Outstanding, Ending Balance 163,655,881 133,258,027